Advanced search
Publication Cover
Future Medicinal Chemistry Volume 15, 2023 - Issue 3
Submit an article Journal homepage
76
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The Connection Between PARP14 and SARS-CoV-2

Amanda L Tauber1 Faculty of Health Sciences & Medicine Bond University Gold CoastQueensland4229AustraliaORCID Iconhttps://orcid.org/0000-0003-4668-9301
ORCID Icon,
Stephanie S Schweiker1 Faculty of Health Sciences & Medicine Bond University Gold CoastQueensland4229AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0978-2569
ORCID Icon &
Stephan M Levonis1 Faculty of Health Sciences & Medicine Bond University Gold CoastQueensland4229AustraliaORCID Iconhttps://orcid.org/0000-0002-6538-7459
ORCID Icon
Pages 225-227 | Received 16 Jan 2023, Accepted 20 Jan 2023, Published online: 03 Feb 2023

References

  • Tauber AL , SchweikerSS, LevonisSM. The potential association between PARP14 and SARS-CoV-2 infection (COVID-19). Future Med. Chem.13(6), 587–592 (2021).
  • Chen F , ShiQ, PeiFet al. A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection. Mol. Syst. Biol.17(8), e10239 (2021).
  • Heer CD , SandersonDJ, VothLSet al. Coronavirus infection and PARP expression dysregulate the NAD metabolome: an actionable component of innate immunity. J Biol. Chem.295(52), 17986–17996 (2020).
  • Desai N , NeyazA, SzabolcsAet al. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat.Comm.11(1), 6319 (2020).
  • Rouchka EC , CharikerJH, AlejandroBet al. Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients. Sci. Rep.11(1), 1–14 (2021).
  • Chen F , ZhangY, SucgangRet al. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors. Sci. Rep.11(1), 2459 (2021).
  • Zheng M , SchultzMB, SinclairDA. NAD+ in COVID-19 and viral infections. Trends Immunol.43(4), 283–295 (2022).
  • Obando-Pereda G . Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach. J. Med. Virol.93(9), 5350–5357 (2021).
  • Alhammad YMO , KashipathyMM, RoyAet al. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase. J.Virol.95(3), 1–20 (2021).
  • Fourkiotis NK , CharalampousP, TsikaACet al. NMR study of human macroPARPs domains: 1H, 15N and 13C resonance assignment of hPARP14 macro domain 2 in the free and the ADPr bound state. Biomol. NMR Assign.16(2), 399–406 (2022).
  • O'Donoghue SI , SchafferhansA, SiktaNet al. SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms. Mol. Syst. Biol.17(9), e10079 (2021).
  • Liu Y , GanJ, WangRet al. DrugDevCovid19: an atlas of anti-COVID-19 compounds derived by computer-aided drug design. Molecules (Basel, Switzerland)27(3), 683 (2022).
  • Vitali L , MerliniA, GalvagnoF et al. Biological and exploitable crossroads for the immune response in cancer and COVID-19. Biomedicines10(10), 2628 (2022).
  • Schweiker SS , TauberAL, SherryME, LevonisSM. Structure, function and inhibition of poly(ADP-ribose)polymerase, member 14 (PARP14). Mini Rev. Med. Chem.18(19), 1659–1669 (2018).
  • Jiang Y , DengY, PangHet al. Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models. Cell Dis.8(1), 38 (2022).
  • Miller R , WentzelAR, RichardsGA. COVID-19: NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity. Med. Hypoth.144, 110044 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.